Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension, October 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 124 articles:
HTML format


 

Single Articles

  1. REZAEIAN N, Asadian S, Parsaee M, Toloueitabar Y, et al
    The predictive role of cardiac magnetic resonance imaging in determining thalassemia patients with intermediately to highly probable pulmonary hypertension.
    Echocardiography. 2021 Oct 1. doi: 10.1111/echo.15210.
    PubMed    
    Abstract available

  2. BERGHAUSEN EM, Janssen W, Vantler M, Gnatzy-Feik LL, et al
    Disrupted PI3K subunit p110alpha signaling protects against pulmonary hypertension and reverses established disease in rodents.
    J Clin Invest. 2021;131.
    PubMed    
    Abstract available

  3. MUNSHI RF, Pellegrini JR Jr, Patel P, Kashin M, et al
    Impact of pulmonary hypertension in patients with acute exacerbation of chronic obstructive pulmonary disease and its effect on healthcare utilization.
    Pulm Circ. 2021;11:20458940211046838.
    PubMed    
    Abstract available

  4. LEON SUAREZ PDC, Rua Figueroa Fernandez de Larrinoa I, Urso S, Marin Esmenota JD, et al
    Reversible pulmonary hypertension with operation of large intramediastinal pseudoaneurysm and anti-inflammatory treatment in patients with Behcet disease.
    BMJ Case Rep. 2021;14.
    PubMed    


  5. MAGLIONE PJ, Gereige JD, Lee TK
    Consideration of pulmonary hypertension in the evaluation of common variable immunodeficiency.
    Ann Allergy Asthma Immunol. 2021;127:513.
    PubMed    


  6. THORE P, Humbert M, Montani D
    Pulmonary hypertension: A rare but severe complication of common variable immunodeficiency.
    Ann Allergy Asthma Immunol. 2021;127:512-513.
    PubMed    


  7. IWASAWA T, Fukui S, Kawakami M, Kawakami T, et al
    Factors related to instrumental activities of daily living in persons with chronic thromboembolic pulmonary hypertension.
    Chron Respir Dis. 2021;18:14799731211046634.
    PubMed    
    Abstract available

  8. AKAY T, Kaymaz C, Ruchan Akar A, Orhan G, et al
    Raising the bar to ultradisciplinary collaborations in management of chronic thromboembolic pulmonary hypertension.
    Turk Gogus Kalp Damar Cerrahisi Derg. 2021;29:417-431.
    PubMed    
    Abstract available

  9. SUZUKI T, Hirose K, Tabei F, Sugishita Y, et al
    An Autopsy Case of Pulmonary Veno-Occlusive Disease Complicated with Chronic Obstructive Pulmonary Disease and Severe Pulmonary Hypertension.
    Int Heart J. 2021;62:1186-1190.
    PubMed    
    Abstract available

  10. TRIANTAFYLLIDI H, Iordanidis D, Mpahara A, Mademli M, et al
    Giant Pulmonary Artery Thrombotic Material, Due to Chronic Thromboembolic Pulmonary Hypertension, Mimics Pulmonary Artery Sarcoma.
    Medicina (Kaunas). 2021;57.
    PubMed    
    Abstract available

  11. KRZYZEWSKA A, Baranowska-Kuczko M, Minczuk K, Kozlowska H, et al
    Cannabinoids-A New Perspective in Adjuvant Therapy for Pulmonary Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  12. KAROOR V, Strassheim D, Sullivan T, Verin A, et al
    The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  13. CRUZ-UTRILLA A, Cristo-Ropero MJ, Calderon-Flores M, Velazquez M, et al
    Sex Differences in Chronic Thromboembolic Pulmonary Hypertension. Treatment Options over Time in a National Referral Center.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  14. WIETESKA-MILEK M, Szmit S, Florczyk M, Kusmierczyk-Droszcz B, et al
    Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  15. BARBEAU S, Gilbert G, Cardouat G, Baudrimont I, et al
    Mechanosensitivity in Pulmonary Circulation: Pathophysiological Relevance of Stretch-Activated Channels in Pulmonary Hypertension.
    Biomolecules. 2021;11.
    PubMed    
    Abstract available

  16. MUELLER-GRAF F, Merz J, Bandorf T, Albus CF, et al
    Correlation of Pulse Wave Transit Time with Pulmonary Artery Pressure in a Porcine Model of Pulmonary Hypertension.
    Biomedicines. 2021;9.
    PubMed    
    Abstract available

  17. WAGENVOORT CA
    [The pathology of the pulmonary vasculature in various forms of pulmonary hypertension [reproduced from G Ital Cardiol 1975;5:1-7]].
    G Ital Cardiol (Rome). 2021;22:793-799.
    PubMed    


  18. KOLB TM, Johnston L, Damarla M, Kass DA, et al
    PDE9A deficiency does not prevent chronic-hypoxic pulmonary hypertension in mice.
    Physiol Rep. 2021;9:e15057.
    PubMed    
    Abstract available

  19. SCOTT TE, Qin CX, Drummond GR, Hobbs AJ, et al
    Innovative Anti-Inflammatory and Pro-resolving Strategies for Pulmonary Hypertension: High Blood Pressure Research Council of Australia Award 2019.
    Hypertension. 2021 Sep 27:HYPERTENSIONAHA12014525.
    PubMed    
    Abstract available

  20. XIAO R, Luo S, Zhang T, Lv Y, et al
    Peptide Blocking Self-Polymerization of Extracellular Calcium-Sensing Receptor Attenuates Hypoxia-Induced Pulmonary Hypertension.
    Hypertension. 2021 Sep 27:HYPERTENSIONAHA12016712.
    PubMed    
    Abstract available

  21. WANG YX, Xiao Y
    [Whether obstructive sleep apnea alone can lead to pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:914-921.
    PubMed    


  22. STRAUSS B, Bisserier M, Obus E, Katz MG, et al
    Right predominant electrical remodeling in a pure model of pulmonary hypertension promotes reentrant arrhythmias.
    Heart Rhythm. 2021 Sep 23. pii: S1547-5271(21)02195.
    PubMed    
    Abstract available

  23. SHIGETOSHI M, Hatanaka K, Ogawa A, Tabuchi I, et al
    Oxygen inhalation can selectively dilate pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension before balloon angioplasty.
    J Cardiol. 2021 Sep 22. pii: S0914-5087(21)00236.
    PubMed    
    Abstract available

  24. GE XY, Zhu TT, Yao MZ, Liu H, et al
    MicroRNA-137 Inhibited Hypoxia-Induced Proliferation of Pulmonary Artery Smooth Muscle Cells by Targeting Calpain-2.
    Biomed Res Int. 2021;2021:2202888.
    PubMed    
    Abstract available

  25. JANSEN K, Constantine A, Condliffe R, Tulloh R, et al
    Pulmonary arterial hypertension in adults with congenital heart disease: markers of disease severity, management of advanced heart failure and transplantation.
    Expert Rev Cardiovasc Ther. 2021;19:837-855.
    PubMed    
    Abstract available

  26. YAO M, Zhang C, Gao C, Wang Q, et al
    Exploration of the Shared Gene Signatures and Molecular Mechanisms Between Systemic Lupus Erythematosus and Pulmonary Arterial Hypertension: Evidence From Transcriptome Data.
    Front Immunol. 2021;12:658341.
    PubMed    
    Abstract available

  27. MARWALI EM, Rayhan M, Roebiono PS
    Nitroglycerin inhalation for acute treatment of pulmonary arterial hypertension in children with congenital heart disease.
    Cardiol Young. 2021;31:1381-1385.
    PubMed    
    Abstract available

  28. MA Y, Chen SS, Jiang F, Ma RY, et al
    Bioinformatic analysis and validation of microRNA-508-3p as a protective predictor by targeting NR4A3/MEK axis in pulmonary arterial hypertension.
    J Cell Mol Med. 2021;25:5202-5219.
    PubMed    
    Abstract available

  29. BROWN Z, Proudman S, Morrisroe K, Stevens W, et al
    Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes.
    Semin Arthritis Rheum. 2021;51:495-512.
    PubMed    
    Abstract available

  30. NICOLEAU S, Fellows A, Wojciak-Stothard B
    Role of Kruppel-like factors in pulmonary arterial hypertension.
    Int J Biochem Cell Biol. 2021;134:105977.
    PubMed    
    Abstract available

  31. LI ZK, Gao LF, Zhu XA, Xiang DK, et al
    LncRNA HOXA-AS3 Promotes the Progression of Pulmonary Arterial Hypertension through Mediation of miR-675-3p/PDE5A Axis.
    Biochem Genet. 2021;59:1158-1172.
    PubMed    
    Abstract available

  32. TAM AYY, Horwell AL, Trinder SL, Khan K, et al
    Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension.
    Int J Biochem Cell Biol. 2021;134:105961.
    PubMed    
    Abstract available

  33. PAUL S, Arudra SKC, Safi F, Anandan V, et al
    Rapidly Progressive Respiratory Failure in Patient With Late Onset Pulmonary Capillary Hemangiomatosis.
    Am J Ther. 2021;28:e141-e143.
    PubMed    


  34. SONAGLIONI A, Cassandro R, Luisi F, Ferrante D, et al
    Correlation Between Doppler Echocardiography and Right Heart Catheterisation-Derived Systolic and Mean Pulmonary Artery Pressures: Determinants of Discrepancies Between the Two Methods.
    Heart Lung Circ. 2021;30:656-664.
    PubMed    
    Abstract available

  35. THANGAPPAN K, Morales DLS, Vu Q, Lehenbauer D, et al
    Impact of mechanical circulatory support on pediatric heart transplant candidates with elevated pulmonary vascular resistance.
    Artif Organs. 2021;45:29-37.
    PubMed    
    Abstract available

  36. WOO KV, Shen IY, Weinheimer CJ, Kovacs A, et al
    Endothelial FGF signaling is protective in hypoxia-induced pulmonary hypertension.
    J Clin Invest. 2021;131.
    PubMed    
    Abstract available

  37. DEMIREL M, Kulahcioglu S, Tokgoz HC, Akbal OY, et al
    Impaired endothelium-dependent and endothelium-independent systemic vasodilatory reserve in pulmonary hypertension regardless the clinical group: A generalized dysfunction beyond the pulmonary arteries?
    Anatol J Cardiol. 2021;25:733-740.
    PubMed    
    Abstract available

  38. EROL C
    Energy drinks, pulmonary hypertension, and many more.
    Anatol J Cardiol. 2021;25:677.
    PubMed    


  39. DALY CM, Griffiths M, Simpson CE, Yang J, et al
    Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
    J Am Heart Assoc. 2021 Oct 8:e021409. doi: 10.1161/JAHA.120.021409.
    PubMed    
    Abstract available

  40. HAGENBURG J, Savale L, Lechartier B, Ghigna MR, et al
    Pulmonary hypertension associated with busulfan.
    Pulm Circ. 2021;11:20458940211030170.
    PubMed    
    Abstract available

  41. KHUGAEV GA, Shmalts AA
    [Morphological assessment of pulmonary vessels in pulmonary arterial hypertension associated with congenital heart disease].
    Arkh Patol. 2021;83:49-57.
    PubMed    
    Abstract available

  42. KEARNEY K, Gold J, Corrigan C, Dhital K, et al
    Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry.
    Respirology. 2021 Oct 5. doi: 10.1111/resp.14162.
    PubMed    
    Abstract available

  43. CHEN DD, Hu WP, Xie L, Xiang GL, et al
    Serum cartilage oligomeric matrix protein is decreased in patients with pulmonary hypertension: a potential protective factor.
    Pulm Circ. 2021;11:0271678X20978861.
    PubMed    
    Abstract available

  44. NABEH OA, Matter LM, Khattab MA, Esraa Menshawey, et al
    "The possible implication of endothelin blockers in the management of COVID19-induced pulmonary hypertension".
    Pulm Pharmacol Ther. 2021 Sep 30:102082. doi: 10.1016/j.pupt.2021.102082.
    PubMed    
    Abstract available

  45. ZHANG Y, Qin D, Li Q, Yang X, et al
    Diagnostic value of cardiac natriuretic peptide on pulmonary hypertension in systemic sclerosis: a systematic review and meta-analysis.
    Joint Bone Spine. 2021 Sep 30:105287. doi: 10.1016/j.jbspin.2021.105287.
    PubMed    
    Abstract available

  46. CUETO-ROBLEDO G, Porres-Aguilar M, Puebla-Aldama D, Barragan-Martinez MDP, et al
    Severe pulmonary hypertension: An important sequel after severe post-acute COVID-19 pneumonia.
    Curr Probl Cardiol. 2021 Sep 30:101004. doi: 10.1016/j.cpcardiol.2021.101004.
    PubMed    


  47. TOI S, Ikeda N, Iijima R, Hara H, et al
    Successful Transcollateral Bidirectional Balloon Pulmonary Angioplasty in a Patient With Chronic Thromboembolic Pulmonary Hypertension.
    JACC Cardiovasc Interv. 2021 Sep 22. pii: S1936-8798(21)01442.
    PubMed    


  48. TORRES-ROJAS MB, Porres-Aguilar M, Mukherjee D, Cueto-Robledo G, et al
    Takayasu's arteritis as a rare cause of group 4 pulmonary hypertension.
    Curr Probl Cardiol. 2021 Sep 29:101008. doi: 10.1016/j.cpcardiol.2021.101008.
    PubMed    


  49. ZHENG Q, Lu W, Yan H, Duan X, et al
    Combination Treatment by HIF-2alpha Antagonist and P53 Agonist Reverses Established Pulmonary Hypertension.
    Br J Pharmacol. 2021 Oct 2. doi: 10.1111/bph.15696.
    PubMed    
    Abstract available

  50. CHOUDHURY P, Bhattacharya A, Dasgupta S, Ghosh N, et al
    Identification of novel metabolic signatures potentially involved in the pathogenesis of COPD associated pulmonary hypertension.
    Metabolomics. 2021;17:94.
    PubMed    
    Abstract available

  51. YAMAKAWA N, Kotooka N, Kato T, Kuroda T, et al
    Cardiac acoustic biomarkers as surrogate markers to diagnose the phenotypes of pulmonary hypertension: an exploratory study.
    Heart Vessels. 2021 Oct 1. pii: 10.1007/s00380-021-01943.
    PubMed    
    Abstract available

  52. TAKSANDE A, Jameel PZ, Pujari D, Taksande B, et al
    Variation in pulmonary function tests among children with sickle cell anemia: a systematic review and meta-analysis.
    Pan Afr Med J. 2021;39:140.
    PubMed    
    Abstract available

  53. ZIMMER A, Teixeira RB, Constantin RL, Fernandes-Piedras TRG, et al
    Thioredoxin system activation is associated with the progression of experimental pulmonary arterial hypertension.
    Life Sci. 2021;284:119917.
    PubMed    
    Abstract available

  54. MARGAROLI C, Russell D
    Extracellular Vesicles: Progress and Challenges in the Study of Human Immunodeficiency Virus and Cocaine-associated Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2021;65:341-342.
    PubMed    


  55. CHAO HY, Hsu CH, Wang ST, Yu CY, et al
    Mediating effect of social support on the relationship between illness concealment and depression symptoms in patients with pulmonary arterial hypertension.
    Heart Lung. 2021;50:706-713.
    PubMed    
    Abstract available

  56. LIU J, Ke X, Wang L, Zhang Y, et al
    Deficiency of cold-inducible RNA-binding protein exacerbated monocrotaline-induced pulmonary artery hypertension through Caveolin1 and CAVIN1.
    J Cell Mol Med. 2021;25:4732-4743.
    PubMed    
    Abstract available

  57. CLEMENTS AC, Walsh JM, Dai X, Skinner ML, et al
    Cardiopulmonary Testing before Pediatric Adenotonsillectomy for Severe and Very Severe Obstructive Sleep Apnea Syndrome.
    Laryngoscope. 2021;131:2361-2368.
    PubMed    
    Abstract available

  58. GULATI G, Ruthazer R, Denofrio D, Vest AR, et al
    Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation.
    J Card Fail. 2021;27:552-559.
    PubMed    
    Abstract available

  59. ALA M, Mohammad Jafari R, Dehpour AR
    Sildenafil Beyond Erectile Dysfunction and Pulmonary Arterial Hypertension: Thinking About New Indications.
    Fundam Clin Pharmacol. 2020 Nov 23. doi: 10.1111/fcp.12633.
    PubMed    
    Abstract available

  60. GOH ZM, Alabed S, Shahin Y, Rothman AMK, et al
    Right Ventricular Adaptation Assessed Using Cardiac Magnetic Resonance Predicts Survival in Pulmonary Arterial Hypertension.
    JACC Cardiovasc Imaging. 2021;14:1271-1272.
    PubMed    


  61. SAYEGH ALC, Silva BM, Ferreira EVM, Ramos RP, et al
    Clinical utility of ventilatory and gas exchange evaluation during low-intensity exercise for risk stratification and prognostication in pulmonary arterial hypertension.
    Respirology. 2021;26:264-272.
    PubMed    
    Abstract available

  62. WEI Q, Li H, Chen Y, Xu X, et al
    Perk heterozygosity ameliorates chronic hypoxia-induced pulmonary hypertension and right ventricular hypertrophy in male rats.
    Clin Exp Hypertens. 2021 Oct 14:1-11. doi: 10.1080/10641963.2021.1984501.
    PubMed    
    Abstract available

  63. NEWMAN J, Boubriak I, Jenkins D, Ng C, et al
    Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset.
    ERJ Open Res. 2021;7.
    PubMed    
    Abstract available

  64. YAZAKI K, Yoshida K, Hyodo K, Kanazawa J, et al
    Pulmonary hypertension due to silicosis and right upper pulmonary artery occlusion with bronchial anthracofibrosis.
    Respir Med Case Rep. 2021;34:101522.
    PubMed    
    Abstract available

  65. CULLIVAN S, McCormack C, O'Callaghan M, Kevane B, et al
    Characteristics of chronic thromboembolic pulmonary hypertension in Ireland.
    Pulm Circ. 2021;11:20458940211048703.
    PubMed    
    Abstract available

  66. WANG RR, Wang TS, Su XL, Mao YM, et al
    [Follow-up study of patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:717-722.
    PubMed    
    Abstract available

  67. GENET L, De Luca D
    Adenosine reverses life-threatening persistent pulmonary hypertension of the neonate refractory to triple vasodilator therapy.
    Cardiol Young. 2021 Oct 13:1-2. doi: 10.1017/S1047951121004157.
    PubMed    
    Abstract available

  68. DEMEROUTI E, Karyofyllis P, Voudris V, Boutsikou M, et al
    Epidemiology and Management of Chronic Thromboembolic Pulmonary Hypertension in Greece. Real-World Data from the Hellenic Pulmonary Hypertension Registry (HOPE).
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  69. PILKA M, Manczak M, Darocha S, Banaszkiewicz M, et al
    Assessment of Clinical Usefulness of Resting Electrocardiogram (PH-ECG Score) in Monitoring the Efficacy of Balloon Pulmonary Angioplasty (BPA) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  70. NUNDLALL N, Playford D, Strange G, Davis TME, et al
    Prevalence, Incidence and Associates of Pulmonary Hypertension Complicating Type 2 Diabetes: Insights from the Fremantle Diabetes Study Phase 2 and National Echocardiographic Database of Australia.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  71. XIAO G, Lian G, Wang T, Chen W, et al
    Zinc-mediated activation of CREB pathway in proliferation of pulmonary artery smooth muscle cells in pulmonary hypertension.
    Cell Commun Signal. 2021;19:103.
    PubMed    
    Abstract available

  72. SOLIVERES E, Mc Entee K, Couvreur T, Fastres A, et al
    Utility of Computed Tomographic Angiography for Pulmonary Hypertension Assessment in a Cohort of West Highland White Terriers With or Without Canine Idiopathic Pulmonary Fibrosis.
    Front Vet Sci. 2021;8:732133.
    PubMed    
    Abstract available

  73. SUN L, Wang C, Zhou Y, Sun W, et al
    Clinical Efficacy and Safety of Different Doses of Sildenafil in the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Network Meta-analysis.
    Front Pharmacol. 2021;12:697287.
    PubMed    
    Abstract available

  74. MOHAMMED S, Vijayvergiya R, Malhotra S, Rohit MK, et al
    A randomized, double-blind, placebo-controlled study to evaluate sildenafil, ambrisentan combination therapy in pulmonary hypertension, particularly of Eisenmenger syndrome.
    Indian Heart J. 2021;73:633-636.
    PubMed    
    Abstract available

  75. HANAOKA H, Ishigaki S, Takei H, Hiramoto K, et al
    Early combination of pulmonary vasodilators prevents chronic kidney disease progression in connective tissue disease-associated pulmonary hypertension.
    Int J Rheum Dis. 2021 Oct 9. doi: 10.1111/1756-185X.14225.
    PubMed    
    Abstract available

  76. MASCHKE SK, Werncke T, Dewald CLA, Becker LS, et al
    Depiction of mosaic perfusion in chronic thromboembolic pulmonary hypertension (CTEPH) on C-arm computed tomography compared to computed tomography pulmonary angiogram (CTPA).
    Sci Rep. 2021;11:20042.
    PubMed    
    Abstract available

  77. SARWAHI V, Galina J, Atlas A, Gecelter R, et al
    Scoliosis Surgery Normalizes Cardiac Function in Adolescent Idiopathic Scoliosis Patients.
    Spine (Phila Pa 1976). 2021;46:E1161-E1167.
    PubMed    
    Abstract available

  78. FUKUMITSU A, Muneuchi J, Watanabe M, Sugitani Y, et al
    Echocardiographic Assessments for Peripartum Cardiac Events in Pregnant Women with Low-Risk Congenital Heart Disease.
    Int Heart J. 2021;62:1062-1068.
    PubMed    
    Abstract available

  79. KRISHNAMACHARY B, Mahajan A, Kumar A, Agarwal S, et al
    Extracellular Vesicle TGF-beta1 Is Linked to Cardiopulmonary Dysfunction in Human Immunodeficiency Virus.
    Am J Respir Cell Mol Biol. 2021;65:413-429.
    PubMed    
    Abstract available

  80. TAKAHASHI Y, Yamamoto K, Sakao S, Takeuchi T, et al
    The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan.
    BMC Pulm Med. 2021;21:89.
    PubMed    
    Abstract available

  81. SHINYA Y, Hiraide T, Momoi M, Goto S, et al
    TNFRSF13B c.226G>A (p.Gly76Ser) as a Novel Causative Mutation for Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2021;10:e019245.
    PubMed    
    Abstract available

  82. HELD M, Weiner S, Walthelm J, Joa F, et al
    [Functional characterization of patients with isolated post-capillary or combined post-capillary and pre-capillary pulmonary hypertension].
    Dtsch Med Wochenschr. 2021 Oct 20:e88-e94. doi: 10.1055/a-1555-0345.
    PubMed    
    Abstract available

  83. WANG Z, Chen J, Babicheva A, Jain PP, et al
    Endothelial Upregulation of Mechanosensitive Channel Piezo1 in Pulmonary Hypertension.
    Am J Physiol Cell Physiol. 2021 Oct 20. doi: 10.1152/ajpcell.00147.2021.
    PubMed    
    Abstract available

  84. NEGI V, Yang J, Speyer G, Pulgarin A, et al
    Computational repurposing of therapeutic small molecules from cancer to pulmonary hypertension.
    Sci Adv. 2021;7:eabh3794.
    PubMed    
    Abstract available

  85. ZHANG W, Tao Z, Xu F, Diao Q, et al
    An Overview of miRNAs Involved in PASMC Phenotypic Switching in Pulmonary Hypertension.
    Biomed Res Int. 2021;2021:5765029.
    PubMed    
    Abstract available

  86. LI L, Yin M, Hu L, Tian X, et al
    Novel Pyrazolo[3,4-b] Pyridine Derivative (HLQ2g) Attenuates Hypoxic Pulmonary Hypertension via Restoring cGKI Expression and BMP Signaling Pathway.
    Front Pharmacol. 2021;12:691405.
    PubMed    
    Abstract available

  87. TAKIMOTO T
    Post-capillary pulmonary hypertension in patients with interstitial lung disease: An important but overlooked phenomenon.
    Respir Investig. 2021 Oct 13. pii: S2212-5345(21)00161.
    PubMed    


  88. CHEN BX, Xing HQ, Gong JN, Guo XJ, et al
    Imaging of cardiac fibroblast activation in patients with chronic thromboembolic pulmonary hypertension.
    Eur J Nucl Med Mol Imaging. 2021 Oct 15. pii: 10.1007/s00259-021-05577.
    PubMed    
    Abstract available

  89. SCHNEIDER SR, Mayer LC, Lichtblau M, Berlier C, et al
    Effect of a day-trip to altitude (2500 m) on exercise performance in pulmonary hypertension: randomised crossover trial.
    ERJ Open Res. 2021;7.
    PubMed    
    Abstract available

  90. KUCUKOGLU MS, Hanta I, Akdeniz B, Gullulu S, et al
    Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study.
    Anatol J Cardiol. 2021;25:721-732.
    PubMed    
    Abstract available

  91. D'ALTO M, Romeo E, Argiento P, Blasi E, et al
    [Pulmonary arterial hypertension or heart failure with preserved ejection fraction? Beyond heart catheterization: a roadmap for challenging cases].
    G Ital Cardiol (Rome). 2021;22:844-850.
    PubMed    
    Abstract available

  92. GALIE N, Dardi F, Manes A, Palazzini M, et al
    [Progress in the treatment of pulmonary vascular diseases].
    G Ital Cardiol (Rome). 2021;22:781-792.
    PubMed    
    Abstract available

  93. BOON GJAM, Janssen SMJ, Barco S, Bogaard HJ, et al
    Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome.
    Thromb Res. 2021;206:66-75.
    PubMed    
    Abstract available

  94. SAMARANAYAKE CB, Warren C, Siewers K, Craig S, et al
    Impact of cyanosis on ventilatory responses during stair climb exercise in Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.
    Int J Cardiol. 2021;341:84-87.
    PubMed    
    Abstract available

  95. MIRI M, Ahmadi M, Hatami M
    Correlation Between Fibroblast Growth Factor-23 and Pulmonary Arterial Hypertension in Hemodialysis Patients.
    Iran J Kidney Dis. 2021;15:300-305.
    PubMed    
    Abstract available

  96. KULTURSAY B, Keskin B, Karagoz A, Akbal OY, et al
    Giant pulmonary artery aneurysm caused by sibutramine-associated pulmonary arterial hypertension: First case in the literature.
    Anatol J Cardiol. 2021;25:512-514.
    PubMed    


  97. GONZAGA LRA, Gomes WJ, Rocco IS, Matos-Garcia BC, et al
    Inflammatory markers in Eisenmenger syndrome and their association with clinical outcomes. A cross-sectional comparative study.
    Int J Cardiol. 2021;342:34-38.
    PubMed    
    Abstract available

  98. MUKHERJEE M, Mercurio V, Hsu S, Mayer SA, et al
    Assessment of right ventricular reserve utilizing exercise provocation in systemic sclerosis.
    Int J Cardiovasc Imaging. 2021;37:2137-2147.
    PubMed    
    Abstract available

  99. JOSEPH MS, Tinney F, Naik A, Parasuraman R, et al
    Right Ventricular Dysfunction and Adverse Outcomes after Renal Transplantation.
    Cardiorenal Med. 2021;11:109-118.
    PubMed    
    Abstract available

  100. HASCOET S, Pontailler M, Le Pavec J, Savale L, et al
    Transplantation for pulmonary arterial hypertension with congenital heart disease: Impact on outcomes of the current therapeutic approach including a high-priority allocation program.
    Am J Transplant. 2021;21:3388-3400.
    PubMed    
    Abstract available

  101. SMOLDERS VFED, Lodder K, Rodriguez C, Tura-Ceide O, et al
    The Inflammatory Profile of CTEPH-Derived Endothelial Cells Is a Possible Driver of Disease Progression.
    Cells. 2021;10.
    PubMed    
    Abstract available

  102. KANAYA T, Miyagawa S, Kawamura T, Sakai Y, et al
    Innovative therapeutic strategy using prostaglandin I2 agonist (ONO1301) combined with nano drug delivery system for pulmonary arterial hypertension.
    Sci Rep. 2021;11:7292.
    PubMed    
    Abstract available

  103. YUCEL H, Vollmer O, Canuet M, Enache I, et al
    Severe pulmonary arterial hypertension and massive ascites in a patient with systemic lupus erythematosus and secondary Sjogren's syndrome.
    Lupus. 2021;30:510-513.
    PubMed    
    Abstract available

  104. REN HH, Niu Z, Guo R, Fu M, et al
    Rhodiola crenulata extract decreases fatty acid oxidation and autophagy to ameliorate pulmonary arterial hypertension by targeting inhibiton of acylcarnitine in rats.
    Chin J Nat Med. 2021;19:120-133.
    PubMed    
    Abstract available

  105. MASCHKE S, Werncke T, Becker LS, Renne J, et al
    Motion Reduction for C-Arm Computed Tomography of the Pulmonary Arteries: Image Quality of a Motion Correction Algorithm in Patients with Chronic Thromboembolic Hypertension During Balloon Pulmonary Angioplasty.
    Rofo. 2021;193:1074-1080.
    PubMed    
    Abstract available

  106. LI M, Wang Y, Li H, Huang Y, et al
    A prediction model of simple echocardiographic variables to screen for potentially correctable shunts in adult patients with pulmonary arterial hypertension associated with atrial septal defects: a cross-sectional study.
    Int J Cardiovasc Imaging. 2021;37:1551-1562.
    PubMed    
    Abstract available

  107. SJOGREN H, Kjellstrom B, Bredfelt A, Steding-Ehrenborg K, et al
    Underfilling decreases left ventricular function in pulmonary arterial hypertension.
    Int J Cardiovasc Imaging. 2021;37:1745-1755.
    PubMed    
    Abstract available

  108. WESTOO C, Norvik C, Peruzzi N, van der Have O, et al
    Distinct types of plexiform lesions identified by synchrotron-based phase-contrast micro-CT.
    Am J Physiol Lung Cell Mol Physiol. 2021;321:L17-L28.
    PubMed    
    Abstract available

  109. CASCINO TM, McLaughlin VV
    Upfront Combination Therapy for Pulmonary Arterial Hypertension: Time to Be More Ambitious than AMBITION.
    Am J Respir Crit Care Med. 2021;204:756-759.
    PubMed    


  110. HASSOUN PM, Farber HW
    Hit Early and Hit Hard in Pulmonary Arterial Hypertension? Not So Fast!
    Am J Respir Crit Care Med. 2021;204:755-756.
    PubMed    


  111. GONCHAROVA EA, Kudryashova TV, Maroli G, Pullamsetti SS, et al
    Matrix Metalloproteinase 8 in Pulmonary Hypertension: The Sheep in the Wolf's Skin?
    Am J Respir Crit Care Med. 2021 Oct 13. doi: 10.1164/rccm.202109-2144.
    PubMed    


  112. BOUCLY A, Savale L, Jais X, Bauer F, et al
    Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;204:842-854.
    PubMed    
    Abstract available

  113. MURTUZA B, Suh E, Gonzalez J, John JB, et al
    Complex Infantile Scimitar Variant: Primary Stenosis of a Meandering Pulmonary Vein.
    Ann Thorac Surg. 2021;112:e315.
    PubMed    


  114. VAN DER BRUGGEN CE, Handoko ML, Bogaard HJ, Marcus JT, et al
    The Value of Hemodynamic Measurements or Cardiac MRI in the Follow-up of Patients With Idiopathic Pulmonary Arterial Hypertension.
    Chest. 2021;159:1575-1585.
    PubMed    
    Abstract available

  115. BRITTAIN EL, Callahan SJ
    Finding Needles in a Haystack: Progress Toward Identifying Pulmonary Arterial Hypertension With the Use of Administrative Data.
    Chest. 2021;159:1713-1714.
    PubMed    


  116. BOGAARD HJ, Aman J
    Neutrophil Elastase: Finding Its Way From Mechanism, via Biomarker to Treatment Target in Pulmonary Hypertension?
    Chest. 2021;160:1177-1178.
    PubMed    


  117. GILLMEYER KR, Nunez ER, Rinne ST, Qian SX, et al
    Development and Validation of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data.
    Chest. 2021;159:1986-1994.
    PubMed    
    Abstract available

  118. HUGHES AL, Hemnes AR
    Metabolics of PH - an update.
    Curr Opin Pulm Med. 2021;27:329-334.
    PubMed    
    Abstract available

  119. FABYAN KD, Holley AB
    Postpulmonary embolism syndrome.
    Curr Opin Pulm Med. 2021;27:335-341.
    PubMed    
    Abstract available

  120. WOLLA CD, Matos JR, Wineland R
    Anesthetic Management of Severe Pulmonary Hypertension in Pregnancy.
    J Cardiothorac Vasc Anesth. 2021 Sep 17. pii: S1053-0770(21)00830.
    PubMed    
    Abstract available

  121. PATERNOSTER G, Bertini P, Innelli P, Trambaiolo P, et al
    Right Ventricular Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis.
    J Cardiothorac Vasc Anesth. 2021;35:3319-3324.
    PubMed    
    Abstract available

  122. DIAZ-RODRIGUEZ N, Nyhan SM, Kolb TM, Steppan J, et al
    How We Would Treat Our Own Pulmonary Hypertension if We Needed to Undergo Cardiac Surgery.
    J Cardiothorac Vasc Anesth. 2021 Sep 24. pii: S1053-0770(21)00843.
    PubMed    
    Abstract available

  123. EVERS PD, Scottoline B, Armsby LB
    Acute right ventricular failure associated with pulmonary hypertension in pediatrics: understanding the hemodynamic profiles.
    J Perinatol. 2021 Oct 18. pii: 10.1038/s41372-021-01231.
    PubMed    
    Abstract available

  124. HOVNANIAN ALD, Costa ELV, Hoette S, Fernandes CJCS, et al
    Electrical impedance tomography in pulmonary arterial hypertension.
    PLoS One. 2021;16:e0248214.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;